Corporate Profile for Hollis-Eden Pharmaceuticals, dated Aug. 2, 2002.Business Editors --(BUSINESS WIRE) The following Corporate Profile is available for inclusion in your files. News releases for this client are distributed by Business Wire and also become part of the leading databases and online services, including all of the leading Internet-based services.
Published Date: Aug. 2, 2002
Company Name: Hollis-Eden Pharmaceuticals
Address: 4435 Eastgate Mall, Suite 400
San Diego, CA 92121
Main Telephone
Number: 858/587-9333
Internet Home
Page Address
(URL) www.holliseden.com
Chief Executive
Officer: Richard Hollis
Chief Financial
Officer: Daniel Burgess
Investor Relations
Contact: Bob Marsella
Business number: 858/587-9333 ext. 415
E-mail address: bmarsella@holliseden.com
Public Relations
Contact: Bob Marsella
Business number: 858/587-9333 ext. 415
E-mail address: bmarsella@holliseden.com
Industry: Biotechnology
Trading Symbol/
Exchange: Nasdaq:HEPH
Company Description: Hollis-Eden Pharmaceuticals, Inc. is a development-stage pharmaceutical company based in San Diego, California “San Diego” redirects here. For other uses, see San Diego (disambiguation). San Diego is a coastal Southern California city located in the southwestern corner of the continental United States. As of 2006, the city has a population of 1,256,951. , engaged in the development of products for the treatment of infectious diseases infectious diseases: see communicable diseases. and immune systems immune system Cells, cell products, organs, and structures of the body involved in the detection and destruction of foreign invaders, such as bacteria, viruses, and cancer cells. Immunity is based on the system's ability to launch a defense against such invaders. disorders. The Company's vision is to become the world leader in immune regulating hormones and their application to numerous diseases. The initial technology development efforts are focused on a series of potent hormones and hormone analogs that the Company believes are key components of the body's natural regulatory system. The Company is utilizing these compounds as drug candidates to regulate the production of key cytokines Cytokines Chemicals made by the cells that act on other cells to stimulate or inhibit their function. Cytokines that stimulate growth are called "growth factors. and enzymes implicated im·pli·cate tr.v. im·pli·cat·ed, im·pli·cat·ing, im·pli·cates 1. To involve or connect intimately or incriminatingly: evidence that implicates others in the plot. 2. in immune response immune response n. An integrated bodily response to an antigen, especially one mediated by lymphocytes and involving recognition of antigens by specific antibodies or previously sensitized lymphocytes. . The Company has reported in a clinical trial that these compounds act on a genetic level to regulate the production of key inflammatory cytokines and enzymes implicated in a variety of infectious diseases and immune system disorders. The Company's goal is to initially apply this technology to the areas of Infectious Diseases, Autoimmune Conditions, Metabolic Diseases, Radiation/Chemotherapy Protection, and Vaccine Enhancement. The Company currently has no sales and the 52 week range for the stock price is $4.01 to $14.25. Approximate net operating budget Noun 1. operating budget - a budget for current expenses as distinct from financial transactions or permanent improvements budget items, operating cost, operating expense, overhead - the expense of maintaining property (e.g. $15 million, approximate net income ($16 million). |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion